Global Positron Emission Tomography (PET) Market Size to Exceed USD 4.22 Billion by 2033: Market Statistics Report

RELEASE DATE: May 2025 Author: Spherical Insights
The Global Positron Emission Tomography (PET) Market Size is Expected to Grow from USD 2.3 Billion in 2023 to USD 4.22 Billion by 2033, at a CAGR of 6.26% during the forecast period 2023-2033

Table of Contents

Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis


Related Topics

IT Solutions for the Integrated Operating Room Market Size Capillary Rheometer Market Size Green Packaging Market Size Embedded Software Market Size

Global Positron Emission Tomography (PET) Market Size to Exceed USD 4.22 Billion by 2033                

According to a research report published by Spherical Insights & Consulting, The Global Positron Emission Tomography (PET) Market Size is Expected to Grow from USD 2.3 Billion in 2023 to USD 4.22 Billion by 2033, at a CAGR of 6.26% during the forecast period 2023-2033.  

        

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Positron Emission Tomography (PET) Market Size, Share, and COVID-19 Impact Analysis, By Product (PET/CT Systems [Low Slice Scanners, Medium Slice Scanners, and High Slice Scanners] and PET/MRI Systems), By Application (Oncology Applications, Neurological Applications, Cardiovascular Applications, and Other Applications), By End-User (Hospital & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, and Other End Users), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

 

The positron emission tomography (PET) market is the worldwide industry concerned with the manufacturing, distribution, and development of PET scanners, radiopharmaceuticals, and associated imaging technologies. PET is a nuclear imaging modality applied in oncology, neurology, and cardiology for the detection of diseases at a molecular level through the monitoring of metabolic and biochemical activity within the body. The market is stimulated by the rising demand for early disease detection, developments in radiotracers, and expanding uses in personalized medicine. Furthermore, the global positron emission tomography (PET) market is driven by rising cancer and neurological disorder cases, increasing demand for early and accurate diagnostics, and advancements in PET imaging technology. Growing healthcare expenditures, expanding applications in cardiology and oncology, and the integration of AI and hybrid imaging systems further fuel market growth during the forecast period. However, the high equipment costs, limited availability in developing regions, reimbursement challenges, complex regulatory approvals, and a shortage of skilled professionals, hindering widespread adoption and market expansion, are key restraints for the growth of the market.

 

The PET/CT systems segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.              

On the basis of the product, the global positron emission tomography (PET) market is divided into PET/CT systems and PET/MRI systems. The PET/CT systems are divided into low slice scanners, medium slice scanners, and high slice scanners. Among these, the PET/CT systems segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to its superior imaging accuracy, rising adoption in oncology and neurology, and increasing demand for early disease detection. Technological advancements, improved diagnostic capabilities, and expanding applications in personalized medicine are expected to drive significant CAGR growth during the forecast period.

 

The oncology applications segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.              

On the basis of the application, the global positron emission tomography (PET) market is segmented into oncology applications, neurological applications, cardiovascular applications, and other applications. Among these, the oncology applications segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is propagated by the rising prevalence of cancer, increasing demand for early and accurate diagnosis, and advancements in PET imaging technology. Growing adoption of PET scans for tumor detection, staging, and treatment monitoring ensures a remarkable CAGR during the forecast period.

 

The hospital & surgical centers segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.

On the basis of the end-user, the global positron emission tomography (PET) market is classified into hospital & surgical centers, diagnostic & imaging clinics, ambulatory care centers, and other end users. Among these, the hospital & surgical centers segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. The segmental growth is expansion by the high patient inflow, advanced imaging infrastructure, and increasing adoption of PET technology for precise diagnostics. Growing investments in healthcare facilities, improved reimbursement policies, and rising demand for early disease detection are expected to drive substantial CAGR growth during the forecast period.

 

North America is projected to hold the largest share of the global positron emission tomography (PET) market over the forecast period.

North America is projected to hold the largest share of the global positron emission tomography (PET) market over the forecast period. The regional growth is attributed to its advanced healthcare infrastructure, high prevalence of cancer and neurological disorders, and strong research investments. Increasing adoption of PET imaging for early diagnosis, favorable reimbursement policies, and continuous technological advancements further drive market growth, ensuring the region maintains its leading position during the forecast period.

 

Asia Pacific is expected to grow at the fastest CAGR growth of the global positron emission tomography (PET) market during the forecast period. The regional growth is boosted to the rising healthcare investments, increasing prevalence of cancer and neurological disorders, and expanding access to advanced diagnostic technologies. Government initiatives, growing awareness about early disease detection, and improving healthcare infrastructure further drive market growth in the region during the forecast period.

 

Company Profiling

Major vendors in the global positron emission tomography (PET) market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Inc., Shanghai United Imaging Healthcare Co. Ltd., Shimadzu Corporation, and others.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Development

In February 2023, United Imaging, a well-known worldwide leader in cutting-edge medical imaging and radiotherapy equipment, took part in Arab Health 2023 as a Platinum partner from January 30 to February 2 in Dubai, United Arab Emirates.  The uCT 960, a 16cm detector/640 slice CT scanner that is the fastest cardiac CT scanner in the world; the uMI 780, an ultra-fast high-resolution digital PET/CT scanner; the uMR 680, a 1.5T Wide Bore MRI System with "3T-like" performance, powered by uAiFI; the uDR 380i Pro, the most portable DR system; and the HD TOF PET/MR uPMR 790, which can produce high-quality images, were among the many state-of-the-art medical imaging devices on display.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global positron emission tomography (PET) market based on the below-mentioned segments:

 

Global Positron Emission Tomography (PET) Market, By Product

  • PET/CT Systems
    • Low Slice Scanners
    • Medium Slice Scanners
    • High Slice Scanners
  • PET/MRI Systems

 

Global Positron Emission Tomography (PET) Market, By Application

  • Oncology Applications
  • Neurological Applications
  • Cardiovascular Applications
  • Other Applications

 

Global Positron Emission Tomography (PET) Market, By End-User

  • Hospital & Surgical Centers
  • Diagnostic & Imaging Clinics
  • Ambulatory Care Centers
  • Other End Users

 

Global Positron Emission Tomography (PET) Market, By Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Recent Insights


Your personal details are safe with us, Privacy Policy.

Thank You!

We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.

+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com

We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies